"Welcome to K2 Medical Research, a privately-owned clinical research facility in the greater Orlando area. We specialize in conducting multiphasic clinical trials that promote the development of innovative and effective medical treatments while maintaining the safety and privacy of our participants. Here at K2, we are committed to fighting the diseases that plague our loved ones and ourselves. By harnessing the power of advanced clinical research and connecting our patients with the treatments of tomorrow, we can improve the health of our local communities, and by extent, the population of our world."

During the past decade, K2 Medical Research conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "K2 Medical Research" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Biogen" with 2 trials sponsored, "Alzheon Inc." with 1 trials sponsored, "Bavarian Nordic" with 1 trials sponsored and "BlackThorn Therapeutics, Inc." with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "K2 Medical Research" #1 collaborator was "National Institute on Aging (NIA)" with 2 trials as a collaborator, "Alzheimer's Clinical Trials Consortium" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator and "Neumora Therapeutics, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "K2 Medical Research" are "Alzheimer Disease" (5 trials), "Alzheimer's Disease" (2 trials), "Alzheimer's Disease Dementia" (1 trials), "Alzheimers Disease" (1 trials) and "Cognitive Dysfunction" (1 trials). Many other conditions were trialed in "K2 Medical Research" in a lesser frequency.

Most popular intervention types in "K2 Medical Research" are "Drug" (12 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Aducanumab" (1 trials), "BIIB080" (1 trials), "BIIB080-matching placebo" (1 trials) and "BTRX-335140" (1 trials). Other intervention names were less common.

The vast majority of trials in "K2 Medical Research" are 14 trials for "All" genders.

Currently, there are NaN active trials in "K2 Medical Research". undefined are not yet recruiting, 8 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in K2 Medical Research, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in K2 Medical Research, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".